Risk Factors for Multiple Myeloma: A Systematic Review of Meta-Analyses
- PMID: 26294217
- DOI: 10.1016/j.clml.2015.06.003
Risk Factors for Multiple Myeloma: A Systematic Review of Meta-Analyses
Abstract
The epidemiology of multiple myeloma (MM) is an increasingly investigated field, with many controversies. This systematic review aims to synthesize meta-analyses examining risk factors for MM so as to provide a comprehensive, parsimonious summary of the current evidence. Eligible meta-analyses were sought in PubMed adopting a predefined algorithm, without any restriction of publication language; end-of-search date was October 10, 2014. The selection of eligible studies and data extraction were performed by working in pairs, independently and blindly to each other; in case of disagreement, consensus with the whole team was reached. Among the 22 ultimately included meta-analyses, 9 examined occupational factors, 4 assessed aspects of lifestyle (smoking, alcohol, body mass index), 5 evaluated the presence of other diseases, and 4 addressed genetic factors as potential risk factors of MM. A vast compendium of significant associations arose, including farming, occupation as a firefighter, occupation as a hairdresser, exposures to chemicals or pesticides, overweight and obesity, patterns of alcohol intake, pernicious anemia, ankylosing spondylitis, gene promoter methylation, and polymorphisms. In conclusion, MM is a multifactorial disease, encompassing a wide variety of risk factors that span numerous life aspects. Further accumulation of evidence through meta-analyses is anticipated in this rapidly growing field.
Keywords: Epidemiology; Meta-analysis; Multiple myeloma; Risk factors; Systematic review.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Bisphosphonates in multiple myeloma: a network meta-analysis.Cochrane Database Syst Rev. 2012 May 16;(5):CD003188. doi: 10.1002/14651858.CD003188.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Dec 18;12:CD003188. doi: 10.1002/14651858.CD003188.pub4. PMID: 22592688 Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.Cochrane Database Syst Rev. 2016 Apr 13;4(4):CD011004. doi: 10.1002/14651858.CD011004.pub2. Cochrane Database Syst Rev. 2016. PMID: 27071857 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3. Cochrane Database Syst Rev. 2007. PMID: 17253483 Free PMC article.
Cited by
-
Childhood infectious diseases and risk of multiple myeloma: an analysis of the Italian multicentre case-control study.Epidemiol Infect. 2018 Sep;146(12):1572-1574. doi: 10.1017/S0950268818001413. Epub 2018 May 30. Epidemiol Infect. 2018. PMID: 29843844 Free PMC article.
-
Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway.Cancer Epidemiol. 2021 Aug;73:101972. doi: 10.1016/j.canep.2021.101972. Epub 2021 Jun 30. Cancer Epidemiol. 2021. PMID: 34216957 Free PMC article.
-
Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma.J Adv Pract Oncol. 2023 Mar;14(2):163-171. doi: 10.6004/jadpro.2023.14.2.7. Epub 2023 Mar 1. J Adv Pract Oncol. 2023. PMID: 37009408 Free PMC article.
-
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency.Cost Eff Resour Alloc. 2025 Mar 5;23(1):6. doi: 10.1186/s12962-024-00600-w. Cost Eff Resour Alloc. 2025. PMID: 40045293 Free PMC article.
-
Quantitative risk of underlying disease conditions for progression from monoclonal gammopathy to multiple myeloma: a nationwide cohort study.ESMO Open. 2025 Jul;10(7):105327. doi: 10.1016/j.esmoop.2025.105327. Epub 2025 Jul 9. ESMO Open. 2025. PMID: 40644760 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials